Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 Oct;24(5):831-6.
doi: 10.3346/jkms.2009.24.5.831. Epub 2009 Sep 23.

The relationship between brachial ankle pulse wave velocity and complement 1 inhibitor

Affiliations
Randomized Controlled Trial

The relationship between brachial ankle pulse wave velocity and complement 1 inhibitor

Yong Min Chae et al. J Korean Med Sci. 2009 Oct.

Abstract

Complement 1 (C1) inhibitor is an acute phase protein with anti-inflammatory properties. The aim of the present study was to elucidate the relationship between brachial ankle pulse wave velocity (baPWV), the parameter of arterial stiffness, and C1 inhibitor. One hundred subjects were randomly enrolled in this study. Data about baPWV, age, gender, hypertension, smoking, and body mass index (BMI) were measured. Blood tests for total cholesterol, low density lipoprotein, high density lipoprotein, triglycerides, hemoglobin A1c, erythrocyte sedimentation rate, C-reactive protein, complement 3, and C1 inhibitor were performed. Based on the Pearson correlation, the C1 inhibitor showed a positive relation to the baPWV (P<0.001). Multiple regression analysis revealed the significant predictors of baPWV were not only the conventional risk factors of arteriosclerosis and/or atherosclerosis, such as age (P<0.001), gender (P<0.001), hypertension (P<0.001), and BMI (P=0.006), but also the acute phase protein, C1 inhibitor (P=0.025). In conclusion, C1 inhibitor is associated with arterial stiffness through its association with increased inflammation.

Keywords: Complement 1 Inhibitor; Pulse Wave Velocity; Stiffness.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Inter-observer and intra-observer reliability of measurements of the brachial ankle pulse wave velocity (cm/sec). (A) Inter-observer reliability (reproducibility) depicts the relationship between three independent measurements by three observers, r1 (observer 1), r2 (observer 2), and r3 (observer 3). The ICC value is 0.8783. (B) Intra-observer reliability (repeatability) shows the relationship between two different measurements by one observer. The ICC value is 0.8927.
Fig. 2
Fig. 2
Linear regression graphs between baPWV and age in both males and females. (A) male, (B) female, baPWVs increase in proportion to the age in both males and females.
Fig. 3
Fig. 3
Linear regression graph between baPWV and C1 inhibitor. Brachial ankle pulse wave velocity showed positive relationship to the serum level of C1 inhibitor. baPWV increases according to the increasing serum level of C1 inhibitor.

Similar articles

Cited by

References

    1. Zanker KS. General introduction to innate immunity: Dr. Jekyl/Mr. Hyde quality of the innate immune system. Contrib Microbiol. 2008;15:12–20. - PubMed
    1. Caliezi C, Wuillemin WA, Zeerleder S, Redondo M, Eisele B, Hack CE. C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacol Rev. 2000;52:91–112. - PubMed
    1. Kalter ES, Daha MR, ten Cate JW, Verhoef J, Bouma BN. Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock. J Infect Dis. 1985;151:1019–1027. - PubMed
    1. Woo P, Lachmann PJ, Harrison RA, Amos N, Cooper C, Rosen FS. Simultaneous turnover of normal and dysfunctional C1 inhibitor as a probe of in vivo activation of C1 and contact activatable proteases. Clin Exp Immunol. 1985;61:1–8. - PMC - PubMed
    1. Kostner KM, Fahti RB, Case C, Hobson P, Tate J, Marwick TH. Inflammation, complement activation and endothelial function in stable and unstable coronary artery disease. Clin Chim Acta. 2006;365:129–134. - PubMed

Publication types

Substances